Global Radiofrequency Ablation Devices Market Assessment & Forecast 2015-2019

Published on: 15-October-2015
Pages: 48
Region: Global
Format: PDF
Report Code: RP000018



Report Description:
The report presents a global analysis of radiofrequency ablation devices market in terms of equipment or components, medical applications and geography. It provides market value with 2013 & 2014 as historical years and forecast of 2015-2019. The analysis considers major applications such as tumor management, pain management, cardiac rhythm management, gynecology, surgery, hypertension and cosmetology. The report also presents current market and forecast for radiofrequency generators, RF catheters and probes, disposables and special capital equipment. RFA has become the image-guided minimally invasive technique of choice today due to its efficacy, safety, and ease of use. This procedure is also often reserved for patients with comorbidities and those who are inoperable for other reasons and one of the major driving factors for this technology is the fact a large number of cases are treated as out-patient procedures reducing hospital stay and expenditure. The global radiofrequency ablation devices market was valued at US$ 3,137.9 million in 2014 and expected to grow to US$ 5,469.7 million by 2019 at a CAGR of 11.5% from 2015 to 2019.

Market Drivers:
Incidence of ineffectiveness of antiarrhythmic drugs is becoming a positive stimulus for treatment by RF ablation.
Minimally invasive out-patient procedure.
Highly mature and clinically proven technology with diverse applications.

Market Inhibitors:
Rising competition from substitute treatment methods such as cryoablation and microwave ablation.
Renal denervation's steep downslide to restrict and contract market expectations from radiofrequency ablation technologies.

Components of Radiofrequency Ablation System Covered In This Report:
Generators
Catheters & Probes
Disposables
Special Capital Equipment

Applications Covered In This Report:
Tumor Management
Cardiac Rhythm Management
General Surgery
Cosmetology
Gynecology
Hypertension

Geographical Regions Covered In This Report:
North America
Europe
Asia-Pacific
Latin America
Middle-East
Africa

Key Players Covered In This Report:
AngioDynamics
Arthrex
AtriCure Inc.
Biotronik
Boston Scientific Corporation
Cosman Medical Inc.
Diros Technology
Fcare Systems
Halyard Health Inc.
Hologic (Novasure)
Johnson & Johnson (Biosense Webster & DePuy Mitek)
Medtronic Inc (Covidien PLC)
St. Jude Medical
Stockert
Stryker Corporation
Sutter Medizintechnik GmbH
Topera (Abbott Laboratories)

Key Questions Answered In This Report:
What is the size of the global radiofrequency ablation systems market?
Who are the major end-users of pharmacy automation?
What is the size of the global radiofrequency ablation market, by medical applications?
What is the size of the North America/Europe/Asia-Pacific/Latin America/Middle-East/Africa radiofrequency ablation devices market?
Who are the key vendors or players in this space?
What is the global market share of key vendors?
What are the major factors driving this market?

Table of Content
Chapter 1 Preface
1.1 Research Scope
1.1.1 Market Segmentation
1.1.2 Postulations
1.2 Methodology of Research
1.2.1 Companies covered in this report

Chapter 2 Precis
2.1 Market Inferences

Chapter 3 Market Dynamics
3.1 Market Drivers
3.1.1 Incidence of ineffectiveness of antiarrhythmic drugs is becoming a positive stimulus for treatment by RF ablation
3.1.2 Minimally invasive out-patient procedure
3.1.3 Highly mature and clinically proven technology with diverse applications
3.2 Market Inhibitors
3.2.1 Rising competition from substitute treatment methods such as cryoablation and microwave ablation
3.2.2 Renal denervation's steep downslide to restrict and contract market expectations from radiofrequency ablation technologies
3.3 Opportunities
3.3.1 New life for RF ablation devices for hypertension
3.3.2 Opportunities in emerging markets
3.3.3 MRI Compatible Catheters

Chapter 4 Radiofrequency Ablation Devices ? Global Market Size Assessment, by Applications, Forecast: 2015 - 2019
4.1 Introduction
4.2 Radiofrequency Ablation Devices Market, by Tumor Management, US$ Mn (2013 - 2019)
4.3 Radiofrequency Ablation Devices Market, by Cardiac Rhythm Management, US$ Mn (2013 - 2019)
4.4 Radiofrequency Ablation Devices Market, by General Surgery, US$ Mn (2013 - 2019)
4.5 Radiofrequency Ablation Devices Market, by Pain Management, US$ Mn (2013 - 2019)
4.6 Radiofrequency Ablation Devices Market, by Cosmetology, US$ Mn (2013 ? 2019)
4.7 Radiofrequency Ablation Devices Market, by Hypertension Management, US$ Mn (2013 ? 2019)
4.8 Radiofrequency Ablation Devices Market, by Gynecology, US$ Mn (2013 ? 2019)
4.9 Radiofrequency Ablation Devices Market, by Other Applications, US$ Mn (2013 ? 2019)

Chapter 5 Radiofrequency Ablation Devices - Global Market Size Assessment, by Products, Forecast: 2015 - 2019
5.1 Introduction
5.2 Radiofrequency Generators Market, US$ Mn (2013 - 2019)
5.3 Radiofrequency Catheters and Probes Market, US$ Mn (2013 - 2019)
5.4 Radiofrequency Disposables Market, US$ Mn (2013 - 2019)
5.5 Radiofrequency Special Capital Equipment Market, US$ Mn (2013 - 2019)

Chapter 6 Radiofrequency Ablation Devices - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019
6.1 North America Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.2 Europe Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.3 Asia-Pacific Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.4 Latin America Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.5 Middle-East Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.6 Africa Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)

Chapter 7 Key Players Analysis: Radiofrequency Ablation Devices Market Share, 2014 (%)
7.1 Key Players Market Share: Radiofrequency Ablation Devices Market, 2014 (%)
7.2 Global Radiofrequency Ablation Devices Market: Recent Developments 2013-2015
7.2.1 Mergers and Acquisitions
7.2.2 Joint Ventures, Expansion and Collaborations
7.2.3 New Product Launches and Approvals
7.3 Competitive Landscape: Strategies

Chapter 8 Epilogue

List of Figures

FIG. 1 Market Segmentation: Global Radiofrequency Ablation Devices Market
FIG. 2 Research Methodology: Global Radiofrequency Ablation Devices Market Assessment
FIG. 3 Global Raadiofrequency Ablation Devices Market Share, by Geography 2014 & 2019 (% Share - US$ Million)
FIG. 4 Radiofrequency Ablation Devices - Global Market Share, by Applications 2014 & 2019 (% Share - US$ Million)
FIG. 5 Global Radiofrequency Ablation Devices Market by Tumor Management 2013 - 2019 (US$ Million)
FIG. 6 Global Radiofrequency Ablation Devices Market for Cardiac Rhythm Management 2013 - 2019 (US$ Million)
FIG. 7 Global Radiofrequency Ablation Devices Market for General Surgery 2013 - 2019 (US$ Million)
FIG. 8 Global Radiofrequency Ablation Devices Market for Pain Management 2013 - 2019 (US$ Million)
FIG. 9 Global Radiofrequency Ablation Devices Market for Cosmetology 2013 - 2019 (US$ Million)
FIG. 10 Global Radiofrequency Ablation Devices Market for Hypertension Management 2013 - 2019 (US$ Million)
FIG. 11 Global Radiofrequency Ablation Devices Market for Gynecology 2013 - 2019 (US$ Million)
FIG. 12 Global Radiofrequency Ablation Devices Market for Other Applications 2013 - 2019 (US$ Million)
FIG. 13 Global Radiofrequency Ablation Devices Market Share, by Products 2014 - 2019 (% Share US$ Millions)
FIG. 14 Global Radiofrequency Generators Market 2013 - 2019 (US$ Million)
FIG. 15 Global Radiofrequency Catheters & Probes Market 2013 - 2019 (US$ Million)
FIG. 16 Global Radiofrequency Disposables Market 2013 - 2019 (US$ Million)
FIG. 17 Global Radiofrequency Ablation Special Capital Equipment Market 2013 - 2019 (US$ Million)
FIG. 18 Key Players Market Share: Radiofrequency Ablation Devices Market, 2014 (%)
FIG. 19 Ablation Devices Market, by Energy Type 2014 (% Share US$ Millions)

List of Tables

TABLE 1 List of companies covered in this report
TABLE 2 Global Radiofrequency Ablation Devices Market, by Geography, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 3 North America Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 4 Europe Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 5 Asia-Pacific Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 6 Latin America Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 7 Middle-East Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 8 Africa Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)

Excerpt:


Radiofrequency is the electromagnetic wave frequency that lies in the range of 3 KHz to 300 GHz and refers to electrical oscillations. RF current penetrates only superficially into the skin unlike other forms of current and this particular aspect is responsible for greater control in thermal ablation of tissue. RF energy has been used in medicine for more than half a century and is currently used in a variety of applications. This report covers all major applications of radiofrequency ablation in healthcare such as cancer/ oncology or tumor management, cardiac rhythm management, pain management, hypertension, cosmetology or dermatology, gynecology and other emerging applications. Cardiac Rhythm Management is one of the most crucial areas in RF ablation devices and is considered a tried and tested treatment option. Atrial fibrillation is one of the most common forms of arrhythmia that occurs in over 35 million people across the world. RF ablation devices are also a boon to people suffering from tumors and cancer which is non-operable. Due to the minimally invasive nature of the procedures, most patients can be out of the hospital within a day and out of the operating room within a few hours of the procedure.
There are a large variety of devices that use RF electrical energy to generate heat. RF ablation catheters are long thin insulated and sheathed wires that have an exposed metal element at one end which delivers the therapeutic dose into the skin. These thin catheters are used for ablating nerves and tissue to reduce pain, arrhythmia and kill cancerous tumors. Some RF devices or probes are thicker and inserted directly into the target area through techniques such as arthroscopy for procedures such as chondroplasty with the help of controlled coagulation and ablation. Glow plasma discharge an effect created by RF energy on an electrode is also used for cutting and dissection of tissue during open invasive surgeries.
This report focuses on the radiofrequency ablation devices market in six geographies of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. The maturity and awareness of the technology in developed countries has ensured the leading position in terms of usage and demand. North America continues to have the greatest acceptance of RF devices and leads the global market followed by Europe. Demand from cosmetic industry has propelled body contouring RF devices in recent years throughout the world. In the past few years, the dynamics have changed quite rapidly for the overall acceptance and penetration of modern healthcare technology in underdeveloped regions as well with emerging economies pumping solid amount of investment in modernizing healthcare infrastructure. SA-BRC expects that new applications such as renal denervation, varicose vein treatment and others will grow significantly creating extremely lucrative market opportunity.
RF technology being the oldest is now facing challenges from emerging ablation technologies that use alternate energy sources such as cryoablation, ultrasound and microwave. The usage of all different types are currently restricted by limitations of technology however in coming years microwave ablation devices in particular are expected to grow in significance. Major players in this market are Medtronic Inc, Johnson & Johnson, Boston Scientific, St. Jude Medical, Stryker, Arthrex, Haylard Health, Angiodynamics, AtriCure, Sutter and Smith & Nephew. Overall the market is quite fragmented and the industry continues to see consolidation in major therapeutic areas such as cardiac ablation and general surgery.

Request Sample Report
10685-B Hazelhurst Drive,
Suite 17411
Houston, TX 77043, U.S.
+1(832)-426-3701
info@sa-brc.com
support@sa-brc.com